论文部分内容阅读
[《医学世界报导》1988年2月]目前对于 Alzheimer 病的确诊仍需在死后进行尸检才能获得,但有不少学者正在寻求一种获得早期诊断的灵敏试验。其中,以美国艾伯特·爱因斯坦医学院的病理学和神经科学教授 Peter Davies 的研究工作最受人注意。他与其同事发现在 Alzheimer 病病人的脑和脑脊液中含有一种数量较大的称为 A68的蛋白质,而在正常成年人的脑中是未能检测到这种蛋白质的,甚至在90岁以上的人亦然.
[Medical World Report, February 1988] At present, the definitive diagnosis of Alzheimer’s disease is still required to be performed after an autopsy. However, many scholars are seeking a sensitive test for early diagnosis. Among them, the work of Peter Davies, a professor of pathology and neuroscience at Albert Einstein College of Medicine in the United States, attracted the most attention. He and his colleagues found that in the brain and cerebrospinal fluid of patients with Alzheimer’s disease, a large amount of protein called A68 was detected, but this protein was not detected in the brain of normal adults, even over 90 years of age. The same applies to people.